| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
21 companies
Redmile Group, LLC is a 10% Owner at ADCT with holdings across 21 companies. Recent SEC Form 4 filings include 12 buys and 7 sells.
Estimated insider holdings value: $691.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | FATE Fate Therapeutics Inc | Director, 10% Owner | Buy | 25,700 | $6.00 | $154,200.00 | +0.2% | -18.1% | -4.0% | |
| Apr 14, 2023 | FATE Fate Therapeutics Inc | Director, 10% Owner | Sell | 302,339 | $5.84 | $1,765,659.76 | -2.3% | -18.1% | -4.0% | |
| Nov 2, 2021 | TRDA Entrada Therapeutics, Inc. | 10% Owner | Buy | 1,000,000 | $20.00 | $20,000,000.00 | +104.8% | -56.6% | -14.1% | |
| Aug 10, 2021 | IVVD Invivyd, Inc. | 10% Owner | Buy | 1,470,000 | $17.00 | $24,990,000.00 | +76.5% | -20.6% | -83.6% | |
| Jul 26, 2021 | ABSI Absci Corp | Director | Buy | 1,875,000 | $16.00 | $30,000,000.00 | +30.5% | -49.7% | -86.4% | |
| Jan 8, 2021 | FATE Fate Therapeutics Inc | Director, 10% Owner | Buy | 327,485 | $85.50 | $27,999,967.50 | +2.6% | - | - | |
| Dec 28, 2020 | APRE Aprea Therapeutics, Inc. | 10% Owner | Sell | 500,000 | $5.58 | $2,791,289.86 | -12.4% | - | - | |
| Oct 14, 2020 | STTK Shattuck Labs, Inc. | Director, 10% Owner | Buy | 3,441,176 | $17.34 | $59,669,342.61 | +11.8% | - | - | |
| Jun 11, 2020 | FATE Fate Therapeutics Inc | Director, 10% Owner | Buy | 1,412,928 | $28.31 | $39,999,991.68 | +12.6% | - | - | |
| Apr 2, 2020 | NGNE Neurogene Inc. | 10% Owner | Sell | 19,668 | $11.19 | $220,154.62 | -0.1% | - | - |